GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Yet federal regulators have declared the blockbuster weight-loss drugs Wegovy (semaglutide ... via telehealth providers will soon need to switch to brand name drugs or pursue other options.

Others don't want to start new customers on the compounded medications because they'll soon need to switch to brand-name medications. Within a year of discontinuing semaglutide, a group of 327 ...

For patients who succeed with tirzepatide for weight loss, switching to semaglutide is not an option for weight-loss maintenance and will likely lead to weight regain.

The following table compares the dosages of Wegovy and Zepbound, which are the brand-name medications ... It’s generally considered safe to switch from semaglutide to tirzepatide.

sold under brand names such as Ozempic for type 2 diabetes and Wegovy for weight loss. Semaglutide appears to help immune cells switch to a more protective state, suggesting its potential to slow ...

If you want to continue GLP-1 therapy, you’ll likely need to switch to a brand-name GLP-1. Examples of these include semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro ...